Cited by 1,203Parkinson's Disease Mechanisms and TreatmentsMitochondrial Function and PathologyNuclear Receptors and Signaling

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants

Open access

Greene, Jessica C., Whitworth, Alexander J., Kuo, Isabella, Andrews, Laurie A., Feany, Mel B., Pallanck, Leo J.·2003·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0737556100PMC PMC153051

Open this paper in CoChat — free account

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra. Several lines of evidence strongly implicate mitochondrial dysfunction as a major causative factor in PD, although the molecular mechanisms responsible for mitochondrial dysfunction are poorly understood. Recently, loss-of-function mutations in the parkin gene, which encodes a ubiquitin-protein ligase, were found to underlie a familial form of PD known as autosomal recessive juvenile parkinsonism (AR-JP). To gain insight into the molecular mechanism responsible for selective cell death in AR-JP, we have created a Drosophila model of this disorder. Drosophila parkin null mutants exhibit reduced lifespan, locomotor defects, and male sterility. The locomotor defects derive from apoptotic cell death of muscle subsets, whereas the male sterile phenotype derives from a spermatid individualization defect at a late stage of spermatogenesis. Mitochondrial pathology is the earliest manifestation of muscle degeneration and a prominent characteristic of individualizing spermatids in parkin mutants. These results indicate that the tissue-specific phenotypes observed in Drosophila parkin mutants result from mitochondrial dysfunction and raise the possibility that similar mitochondrial impairment triggers the selective cell loss observed in AR-JP.

Integrity signals

Registry

Crossref · 10.1073/pnas.0737556100

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
Brand, A. H., & Perrimon, N. (1993) · Development · doi:10.1242/dev.118.2.401 · Cited by 9,510
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
A Drosophila model of Parkinson's disease
Feany, M. Β., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,156
Self-citation
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,273
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227
Ubiquitination of a new form of α-synuclein by parkin from human brain: implications for Parkinson's disease
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053

Show all 34 references

Sorted by citations

Items 901–1,000 of 1,000

Monogenetic Forms of Parkinson’s Disease – Bridging the Gap Between Genetics and Biomarkers
Tönges, L., Kwon, E. H., & Klebe, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.822949 · Cited by 9
Mitochondrial Fission and Fusion
Hewitt, V. L., & Whitworth, A. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00003-1 · Cited by 10
Self-citation
A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson’s disease by highlighting the use of cybrid models
Lang, M., Grünewald, A., Pramstaller, P. P., Hicks, A. A., & Pichler, I. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04304-3 · Cited by 8
Animal Models and the Science of Movement Disorders
LeDoux, M. S. (2005) · Elsevier eBooks · doi:10.1016/b978-012088382-0/50003-7 · Cited by 8
The On-Ranch Economics of Riparian Zone Cattle Grazing Management
Unterschultz, J. R., Miller, J., & Boxall, P. C. (2004) · Environmental Management · doi:10.1007/s00267-003-0010-9 · Cited by 8
Mitochondria and Parkinson's Disease
Simon, D. K., Chu, C. T., & Swerdlow, R. H. (2011) · Parkinson s Disease · doi:10.4061/2011/261791 · Cited by 8
Autophagy, Mitochondrial Dynamics, and Retinal Diseases
Kaden, T. R., & Li, W. (2013) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0b013e31829d3e33 · Cited by 8
Induction of oxidative stress biomarkers following whole-body irradiation in mice
Shimura, T., Nakashiro, C., Narao, M., & Ushiyama, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240108 · Cited by 8
Demented flies? using Drosophila to model human neurodegenerative diseases
Michno, K., van de Hoef, D. L., Wu, H., & Boulianne, G. L. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00448.x · Cited by 8
Mitochondrial Pathology in Muscle of a Patient with a Novel Parkin Mutation
Hanagasi, H. A., Serdaroglu, P., Ozansoy, M., Basak, N. A., Tașlı, H., & Emre, M. (2009) · International Journal of Neuroscience · doi:10.1080/00207450903088019 · Cited by 8
In vivo and in silico models of Drosophila for Parkinson's disease
Cesur, M. F., Strazdins, R., Sarkar, S., & Çakır, T. (2025) · FEBS Journal · doi:10.1111/febs.70140 · Cited by 7
The PP2A-B55α phosphatase is a master regulator of mitochondrial degradation and biogenesis
Cianfanelli, V., Nanni, M., Corrà, S., Mauri, S., Sumpton, D. P., Lilla, S., Cegli, R. D., Bordi, M., Milletti, G., Ferraina, C., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw7376 · Cited by 8
Usp14 down-regulation corrects sleep and circadian dysfunction of a Drosophila model of Parkinson’s disease
Favaro, M., Mauri, S., Bernardo, G., Zordan, M. A., Mazzotta, G. M., & Ziviani, E. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1410139 · Cited by 7
Expression of human amyloid precursor protein in the skeletal muscles of Drosophila results in age- and activity-dependent muscle weakness
Kim, C., Srivastava, S., Rice, M., Godenschwege, T. A., Bentley, B., Ravi, S., Shao, S., Woodard, C. T., & Schwartz, L. M. (2011) · BMC Physiology · doi:10.1186/1472-6793-11-7 · Cited by 7
Modelling in miniature: Using Drosophila melanogaster to study human neurodegeneration
Lambrechts, R. A., Faber, A. I. E., & Sibon, O. C. M. (2017) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2018.09.004 · Cited by 8
Loss of parkin causes endoplasmic reticulum calcium dyshomeostasis by upregulation of reticulocalbin 1
Rybarski, M. O., Mrohs, D., Osenberg, K., Hemmersbach, M., Pfeffel, K., Steinkamp, J., Schmidt, D., Violou, K., Schäning, R., Schmidtke, K., et al. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15917 · Cited by 7
Neurodegeneration in Parkinson’s Disease: Genetics Enlightens Physiopathology
Corti, O., Fournier, M., & Brice, A. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_17 · Cited by 7
Suppression of Nrdp1 toxicity by Parkin in Drosophila models
Tan, Y., Yu, F., Pereira, A., Morin, P., & Zhou, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.104 · Cited by 7
Demise of the Flies
Bakhoum, M. F., & Jackson, G. R. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00011-x · Cited by 7
Monitoring Mitochondrial Changes by Alteration of the PINK1-Parkin Signaling in Drosophila
Inoshita, T., Shiba‐Fukushima, K., Meng, H., Hattori, N., & Imai, Y. (2017) · Methods in molecular biology · doi:10.1007/7651_2017_9 · Cited by 7
Parkinson’s Disease: Insights from Drosophila Model
Ayajuddin, M., Das, A., Phom, L., Modi, P., Chaurasia, R., Koza, Z., Thepa, A., Jamir, N., Singh, P. R., Longkumer, S., et al. (2018) · InTech eBooks · doi:10.5772/intechopen.72021 · Cited by 7
Infection triggers symptoms similar to those of Parkinson’s disease in mice lacking PINK1 protein
Herrick, M. K., & Tansey, M. G. (2019) · Nature · doi:10.1038/d41586-019-02094-6 · Cited by 7
[Copper intoxication decreases lifespan and induces neurologic alterations in Drosophila melanogaster].
Arcaya, J. L., Tejeda, C. M., Salazar, U. Y., Silva, E. J., Urdaneta, K., & Varela, K. (2013) · PubMed · Cited by 7
Mitochondria in the etiology of Parkinson's disease
Schapira, A. H. V. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83022-3 · Cited by 7
Programmed Cell Death in Insect Neuromuscular Systems during Metamorphosis
Fahrbach, S. E., Nambu, J. R., & Schwartz, L. M. (2005) · Elsevier eBooks · doi:10.1016/b0-44-451924-6/00027-2 · Cited by 7
Mitochondrial Injury: A Hot Spot for Parkinsonism and Parkinson's Disease?
Giasson, B. I. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.48.pe42 · Cited by 7
Mitochondrial quality control in health and disease: mechanisms and therapeutic targets
Creus, A., Mohapatra, S., Ortega, L., & Sebastián, D. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02813-2 · Cited by 7
Parkinson’s Disease and Parkin: Insights from Park2 Knockout Mice
Stephenson, S. E. M., Juliet, M., & Paul, J. (2012) · InTech eBooks · doi:10.5772/18148 · Cited by 6
Drosophila melanogaster Parkin ubiquitinates peanut and septin1 as an E3 ubiquitin–protein ligase
Bae, Y.-J., Kang, S.-J., & Park, K. S. (2007) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2007.01.007 · Cited by 6
In Vivo Animal Modeling
Wangler, M. F., & Bellen, H. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803077-6.00012-6 · Cited by 6
Complementary Transcriptomic and Proteomic Analysis in the Substantia Nigra of Parkinson’s Disease
Dong, B., Niu, Z.-Q., Zhang, J., Zhou, Y.-J., Meng, F., & Dong, A. (2021) · Disease Markers · doi:10.1155/2021/2148820 · Cited by 6
The dual role of heme oxygenase in regulating apoptosis in the nervous system of Drosophila melanogaster
Abaquita, T. A. L., Damulewicz, M., Tylko, G., & Pyza, E. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1060175 · Cited by 6
A Novel Lenticular Arena to Quantify Locomotor Competence in Walking Fruit Flies
MEKDARA, N. T., GOTO, J. J., Choudhury, S. A., Mekdara, P. J., YINGST, N., CAO, Y., BERG, O., & Müller, U. K. (2012) · Journal of Experimental Zoology Part A Ecological Genetics and Physiology · doi:10.1002/jez.1731 · Cited by 6
Neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease
Cebrián, C., & Sulzer, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00008-0 · Cited by 7
Use of Drosophila as a model organism in medicine
Prasad, B., & Hegde, S. N. (2010) · Journal of Medicine and Medical Sciences · Cited by 6
PINK1-Parkin-mediated regulation of mitochondrial dynamics: A core function parallel to mitophagy control
Jiang, H. (2025) · Mitochondrial Communications · doi:10.1016/j.mitoco.2025.10.002 · Cited by 5
NIPSNAP1 and NIPSNAP2 facilitate healthy aging independent of mitophagy
Lv, J., Wang, J., Chen, Q., Zhong, Q., Zhan, H., Guo, Q., Li, J., Guo, N., Yu, F., Tong, J., et al. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156324 · Cited by 5
The Bac Transgenic Approach to Study Parkinson's Disease in Mice
Yang, X. W., & Lu, X. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00019-1 · Cited by 5
Temperature and sex shape Zika virus pathogenicity in the adult Brat brain: A Drosophila model for virus-associated neurological diseases
Tafesh‐Edwards, G., Kalukin, A. A., Bunnell, D., Chtarbanova, S., & Eleftherianos, I. (2023) · iScience · doi:10.1016/j.isci.2023.106424 · Cited by 5
Clinical Trial Highlights: Modulators of Mitochondrial Function
Capriglia, F., Burgess, T., Bandmann, O., & Mortiboys, H. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-239003 · Cited by 5
Successes of Modelling Parkinson Disease in Drosophila
Brian, E. (2012) · InTech eBooks · doi:10.5772/18844 · Cited by 5
Mitochondrial dynamics in degenerative disease and disease models
Merzetti, E. M., & Staveley, B. E. (2013) · Neuroscience Discovery · doi:10.7243/2052-6946-1-8 · Cited by 5
Mitochondrial dysfunction in Parkinson’s disease: a possible target for neuroprotection
Gleave, J. A., Perri, P. D., & Nash, J. E. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1337-8 · Cited by 5
Monitoring α-Synuclein Proteotoxicity in Drosophila Models
Szabó, Á., & Tofaris, G. K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9124-2_15 · Cited by 5
The dysregulated Pink1- Drosophila mitochondrial proteome is partially corrected with exercise
Ebanks, B., Ingram, T. L., Katyal, G., Ingram, J. R., Moisoi, N., & Chakrabarti, L. (2021) · Aging · doi:10.18632/aging.203128 · Cited by 6
Parkin expression in human skeletal muscle
Serdaroglu, P., Tasli, H., Hanagasi, H. A., & Emre, M. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2005.04.005 · Cited by 5
Non-mammalian animal models of Parkinson's disease for drug discovery
Lim, K. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903527675 · Cited by 5
Identifying potential PARIS homologs in D. melanogaster
Merzetti, E. M., & Staveley, B. E. (2016) · Genetics and Molecular Research · doi:10.4238/gmr15048934 · Cited by 5
1,5-Anhydro-D-fructose Protects against Rotenone-Induced Neuronal Damage In Vitro through Mitochondrial Biogenesis
Kasamo, Y., Kikuchi, K., Yamakuchi, M., Otsuka, S., Takada, S., Kambe, Y., Ito, T., Kawahara, K.-I., Arita, K., Yoshimoto, K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189941 · Cited by 5
Roles of Fibroblasts in Microenvironment Formation Associated with Radiation-Induced Cancer
Shimura, T. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_13 · Cited by 5
Drosophila ZIP13 over‐expression or transferrin1 RNAi influences the muscle degeneration of Pink1 RNAi by elevating iron levels in mitochondria
Xue, J., Li, G., Ji, X., Liu, Z. H., Wang, H. L., & Xiao, G. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15574 · Cited by 5
Current concepts on the etiology and pathogenesis of Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00005-6 · Cited by 5
Toxicity evaluation of novel imidacloprid nanoribbons, using somatic mutation and fitness indexes in Drosophila melanogaster
Vidal, L. M., Pimentel, E., Escobar-Alarcón, L., Cruces, M. P., Jiménez, E., Suárez, H., & Leyva, Y. (2024) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2024.2316649 · Cited by 4
Insights into PINK1/Parkin function and dysfunction from Drosophila models
Park, S., Kozhushko, N., Wight, T. H., & Whitworth, A. J. (2025) · Biochemical Journal · doi:10.1042/bcj20253459 · Cited by 5
Self-citation
The pathological role of Pael-receptor/GPR37 in AR-JP
Takahahshi, R. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.05.013 · Cited by 4
Exploring the Efficient Natural Products for the Therapy of Parkinson’s Disease via Drosophila Melanogaster (Fruit Fly) Models
Zhang, W., Ju, Y., Ren, Y., Miao, Y., & Wang, Y. (2024) · Current Drug Targets · doi:10.2174/0113894501281402231218071641 · Cited by 4
Drosophila Models of Parkinson Disease
Pallanck, L. J., & Whitworth, A. J. (2005) · Elsevier eBooks · doi:10.1016/b978-012088382-0/50014-1 · Cited by 4
Self-citation
Animal models of Parkinson’s disease and related disorders
Petzinger, G. M., & Jakowec, M. W. (2013) · CRC Press eBooks · doi:10.1201/b14361-17 · Cited by 4
Vexed mutations promote degeneration of dopaminergic neurons through excessive activation of the innate immune response
Davis, J., Kolaski, E., & Babcock, D. T. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00417-5 · Cited by 5
Insights into the promising prospect of pharmacological approaches targeting mitochondrial dysfunction in major human diseases: At a glance
Rahman, M. M., Sarker, M. T., Ahmed, S., Uddin, M. N., Islam, M. R., Islam, M. R., Das, S., Mukherjee, N., Hemeg, H. A., Rauf, A., et al. (2023) · Process Biochemistry · doi:10.1016/j.procbio.2023.07.007 · Cited by 4
Repeat length of C9orf72-associated glycine–alanine polypeptides affects their toxicity
Morón-Oset, J., Fischer, L. K., Jauré, N., Zhang, P., Jahn, A. J., Supèr, T., Pahl, A., Isaacs, A. M., Grönke, S., & Partridge, L. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01634-6 · Cited by 5
Exploring the therapeutic potential of the mitochondrial transfer-associated enzymatic machinery in brain degeneration
Luque‐Campos, N., Riquelme, R., Molina, L., Canedo-Marroquín, G., Vega-Letter, A. M., Luz‐Crawford, P., & Bustamante-Barrientos, F. A. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1217815 · Cited by 4
Pink1 and parkin demonstrate multifaceted roles when co-expressed with Foxo
Todd, A. M., & Staveley, B. E. (2013) · Advances in Parkinson s Disease · doi:10.4236/apd.2013.21002 · Cited by 4
PARKIN/PINK1 Pathway for the Selective Isolation and Degradation of Impaired Mitochondria
Narendra, D. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_8 · Cited by 4
Redox Imbalance
Berg, D. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50148-4 · Cited by 4
Genetic Factors in Parkinsons Disease and Potential Therapeutic Targets
Feng, J. (2003) · Current Neuropharmacology · doi:10.2174/1570159033477053 · Cited by 4
Targeting of kinases to treat neurodegenerative diseases
Shomali, T., & Trempe, J.-F. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100128 · Cited by 4
The regulation of Xrp1 expression by uORFs and main ORF sequences and its function in Drosophila disease models
Katow, H., Nguyen, T., Park, S. H., & Ryoo, H. D. (2026) · PLoS Genetics · doi:10.1371/journal.pgen.1012203 · Cited by 3
Detoxification of Chlorfenapyr by a Parkin-GSTd2 Module in Bactrocera dorsalis (Diptera: Tephritidae)
Xie, C., Zeng, B., Du, X., Yan, S., Shen, J., & Zhang, J. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c06416 · Cited by 3
Taking flight, the use of Drosophila melanogaster for neuroscience research in Uruguay
Budelli, G., Ferreiro, M. J., & Bolatto, C. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.006 · Cited by 3
Mitophagy
Sica, V., Izzo, V., Pedro, J. M. B., Zamzami, N., & Maiuri, M. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802936-7.00003-9 · Cited by 4
Ecofriendly silver nanoparticle synthesis, physicochemical characterization from Datura stramonium, and its biological applications in Parkinson Drosophila model
Thokchom, B., Bhavi, S. M., Singh, S. R., Abbigeri, M. B., Padti, A. C., Kulkarni, S. R., Sailaja, V., & Yarajarla, R. B. (2025) · ASPET Discovery · doi:10.1016/j.aspetd.2025.100008 · Cited by 3
Parkinson's Disease
Penney, E. B., & McCabe, B. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00024-5 · Cited by 3
Un peu de Rose dans la maladie de Parkinson
Berthier, A. (2008) · médecine/sciences · doi:10.1051/medsci/2008242118 · Cited by 3
Electron Transport Chain
Aerts, L., & Morais, V. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00002-x · Cited by 3
Aging in Drosophila melanogaster
Gumeni, S., & Trougakos, I. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11410-2 · Cited by 3
Intracellular delivery of Parkin-RING0-based fragments corrects Parkin-induced mitochondrial dysfunction through interaction with SLP-2
Zanon, A., Guida, M., Lavdas, A. Α., Corti, C., Rueda, M. P. C., Negro, A., Pramstaller, P. P., Domingues, F. S., Hicks, A. A., & Pichler, I. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04850-3 · Cited by 4
Time Flies: Autophagy During Ageing in Drosophila
Schultz, S. W., Brech, A., & Ioannis, P. (2013) · InTech eBooks · doi:10.5772/55396 · Cited by 3
Fluorescent Parkin Cell-Based Assay Development for the Screening of Drugs against Parkinson Disease
Villacé, P., Mella, R. M., Roura‐Ferrer, M., Valcárcel, M., Salado, C., Castilla, A., & Kortázar, D. (2016) · SLAS DISCOVERY · doi:10.1177/1087057116671498 · Cited by 3
Overexpression of Buffy enhances the loss of parkin and suppresses the loss of Pink1 phenotypes in Drosophila
M'angale, P. G., & Staveley, B. E. (2016) · Genome · doi:10.1139/gen-2016-0165 · Cited by 3
Nörodejeneratif Hastalık Araştırmalarında Drosophila melanogaster Modeli
HAZIR, C., Bora, G., & Erdem‐Yurter, H. (2020) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.732671 · Cited by 3
Genetics of Parkinson's Disease—An Overview
Klein, C. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00002-7 · Cited by 3
Neurodegeneration caused by ER stress?
Takahashi, R. (2004) · Folia Pharmacologica Japonica · doi:10.1254/fpj.124.375 · Cited by 3
Mitophagy
King, L., & Plun‐Favreau, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00005-5 · Cited by 6
Drosophila melanogaster (Meigen, 1830): A Potential Model for Human Diseases
Adesola, R. O., Lawal, J. T., & Oladele, O. E. (2021) · doi:10.5281/zenodo.18514105 · Cited by 3
RING Fingers and Relatives: Determinators of Protein Fate
Lorick, K. L., Tsai, Y. C., Yang, Y., & Weissman, A. M. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch4 · Cited by 3
RNA Interference Technologies for Understanding and Treating Neurodegenerative Diseases
Lu, B. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:6:1:001 · Cited by 3
Genetics of Parkinson's Disease
Sinha, K. (2005) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10587_5 · Cited by 3
Mitochondrial CISD1/Cisd accumulation blocks mitophagy and genetic or pharmacological inhibition rescues neurodegenerative phenotypes in Pink1/parkin modelsPreprint
Martinez, A., Sánchez-Martínez, Á., Pickering, J. T., Twyning, M. J., Terriente-Félix, A., Chen, P., Chen, C., & Whitworth, A. J. (2023) · Research Square · doi:10.21203/rs.3.rs-2933559/v1 · Cited by 3
Self-citation
Ablation of Mitochondrial RCC1-L Induces Nigral Dopaminergic Neurodegeneration and Parkinsonian-like Motor SymptomsPreprint
Ellioff, K. J., Osting, S., Lentine, A., Welper, A. D., Bürger, C., & Greenspan, D. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.01.567409 · Cited by 3
Synergism of IP3R and Parkin mutants identifies mitochondrial stress as an early feature of Parkinson's disease
Dileep, M., Sharma, A., Kasturacharya, N., Nizami, S. K., Manjila, S. B., Bhan, A., & Hasan, G. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052146 · Cited by 2
Microglial Biology in Neuroinflammatory Disease: Pharmaco-industrial Approach to Target Validation
Möller, T., Wes, P. D., & Doller, D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0974-2_9 · Cited by 2
1950s–1990s: The pioneering era of insect neuroscience in Uruguay
Silvera, M. C., & Prieto, D. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.01.027 · Cited by 2
Loss of Drosophila ribosomal protein S6 kinase II causes mitochondrial dysfunction and cell death
Deng, T., Kalmár, L., Loh, S. H. Y., Pardo, O. E., & Martins, L. M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052374 · Cited by 2
park+/+ and park−/− Drosophila have sexually dimorphic brain redox chemistry
Juba, A. N., Stwalley, B., Margaryan, T., Hamel, R., Foley, A. N., Jones, T. B., Tovmasyan, A. G., & Buhlman, L. M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052250 · Cited by 2
Actinomyces viscosus promotes neuroprotection in C. elegans models of Parkinson’s disease
Ngana, G. S., Bernardo, M. A. D., Surette, M. G., & MacNeil, L. T. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112061 · Cited by 3
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?
Mannan, A., Sharma, A., & Singh, T. G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05263-z · Cited by 2
Bases moléculaires de la maladie de Parkinson
Lesage, S., & Brice, A. (2010) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(10)51090-x · Cited by 2
Phosphorylation Events in Selective Mitophagy: Possible Biochemical Markers?
Zhang, W., Wu, H., Liu, L., Zhu, Y., & Chen, Q. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0033-8 · Cited by 2
Oxidative Stress in Parkinson's Disease; Parallels Between Current Animal Models, Human Studies and Cells
Norazit, A., Mellick, G. D., & Meedeniy, A. C. B. (2012) · InTech eBooks · doi:10.5772/33459 · Cited by 2

Authors: Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J.
Affiliations: Brigham and Women's Hospital (US)
Department of Genome Sciences, University of Washington, P.O. Box 357730, Seattle, WA 98195; and Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
ORCID: Whitworth, Alexander J.
Pallanck, Leo J.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2003-03-17
Volume: 100
Issue: 7
Pages: 4078-4083
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0737556100
PMC: PMC153051
OpenAlex: W2055124287
Cited by: 1,203
References: 34
Citations by year: 2026: 17 · 2025: 29 · 2024: 34 · 2023: 38 · 2022: 49 · 2021: 64 · 2020: 68 · 2019: 50 · 2018: 64 · 2017: 54 · 2016: 69 · 2015: 56 · 2014: 55 · 2013: 64 · 2012: 67
FWCI: 27.97
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Neurological Disorders and Stroke (R01NS041780, 1R01NS41780-01, 1R01NS41536-01, R01NS041536)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords: Parkin, Parkinson's disease, autosomal recessive juvenile parkinsonism, mitochondrial dysfunction, muscle degeneration, apoptosis, Drosophila model, ubiquitin-protein ligase, spermatid individualization, male sterility, locomotion defects, lifespan, selective cell death
MeSH terms: Amino Acid Sequence, Animals, Cloning, Molecular, Drosophila, Ligases, Longevity, Male, Mitochondria, Molecular Sequence Data, Nerve Degeneration, Parkinson Disease, Recombinant Proteins, Spermatids, Mutagenesis, Sequence Alignment, Apoptosis, Sequence Homology, Amino Acid, Muscle, Skeletal, Ubiquitin-Protein Ligases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks